Texas Instruments Incorporated vs Novartis AG
์๊ฐ์ ๋ฐ๋ฅธ ์๊ฐ์ด์ก ๋น๊ต
Texas Instruments Incorporated
$260.0B
์์ #54
Novartis AG
$272.5B
์์ #51
์๊ฐ์ ๋ฐ๋ฅธ ์๊ฐ์ด์ก
์ฃผ์ ์๊ฐ
- Texas Instruments Incorporated์ด(๊ฐ) 2021๋ ๊น์ง Novartis AG์(๋ฅผ) ์ถ์ํ์ต๋๋ค
- Novartis AG์ด(๊ฐ) 2022๋ ๊น์ง Texas Instruments Incorporated์(๋ฅผ) ์ถ์ํ์ต๋๋ค
์ฐ๋๋ณ ๋น๊ต
| ์ฐ๋ | Texas Instruments Incorporated | Novartis AG | ์ ๋ |
|---|---|---|---|
| 2026 | $260.0B | $272.5B | Novartis AG |
| 2025 | $156.1B | $227.3B | Novartis AG |
| 2024 | $163.4B | $177.6B | Novartis AG |
| 2023 | $144.4B | $163.8B | Novartis AG |
| 2022 | $135.7B | $146.3B | Novartis AG |
| 2021 | $150.6B | $134.5B | Texas Instruments Incorporated |
| 2020 | $128.1B | $134.7B | Novartis AG |
| 2019 | $97.3B | $142.4B | Novartis AG |
| 2018 | $69.7B | $110.8B | Novartis AG |
| 2017 | $75.1B | $104.0B | Novartis AG |
| 2016 | $51.2B | $89.6B | Novartis AG |
| 2015 | $37.4B | $100.4B | Novartis AG |
| 2014 | $35.6B | $103.4B | Novartis AG |
| 2013 | $28.4B | $76.6B | Novartis AG |
| 2012 | $19.4B | $59.2B | Novartis AG |
| 2011 | $17.9B | $52.5B | Novartis AG |
| 2010 | $19.6B | $51.1B | Novartis AG |
| 2009 | $15.4B | $50.7B | Novartis AG |
| 2008 | $9.0B | $44.5B | Novartis AG |
| 2007 | $19.0B | $50.6B | Novartis AG |
| 2006 | $16.3B | $55.9B | Novartis AG |
| 2005 | $18.0B | $53.9B | Novartis AG |
| 2004 | $13.8B | $43.8B | Novartis AG |
| 2003 | $16.4B | $42.0B | Novartis AG |
| 2002 | $8.3B | $36.9B | Novartis AG |
| 2001 | $15.5B | $43.1B | Novartis AG |
| 2000 | $26.2B | $50.7B | Novartis AG |
| 1999 | $26.6B | $40.7B | Novartis AG |
| 1998 | $11.8B | $46.3B | Novartis AG |
| 1997 | $6.1B | $40.1B | Novartis AG |
| 1996 | $4.3B | $24.5B | Novartis AG |
| 1995 | $3.4B | $16.9B | Novartis AG |